Mitokinin Company
Mitokinin is operates in the healthcare industry focusing on biotechnology business. It launches medicinal chemistry effort to generate kinetin analogs optimized for activating PINK1. It plans to develop the analog or optimized variants to treat Parkinson's disease.
Industry:
Small&Large Molecules
Headquarters:
California, United States
Founded Date:
2017
Register and Claim Ownership